Jimmy O. Yang Upgrades His Vision With EVO

Actor and Stand-up Comedian

Web jimmy testimonail page masthead desktop

Jimmy O. Yang's Life-Changing Journey with EVO ICL

Jimmy O. Yang, the talented American actor, stand-up comedian, and writer, has always had a passion for entertainment and storytelling. But for years, he faced a common struggle shared by millions worldwide – the hassle of glasses and contact lenses. Discover how EVO Implantable Collamer® Lenses (ICL) changed his vision and his life, highlighting the life-changing benefits of this procedure in his own words.

0
Web jimmy testimonial page video thumbnail

The Inconvenience of Glasses and Contacts

Jimmy's vision correction journey began when he started wearing glasses at the age of 13. Over the years, the constant need to put on and take off his glasses had become an accepted part of his life. He tried contact lenses during college, but they never truly felt comfortable. For a while, Jimmy resigned himself to the inconveniences of glasses and contacts. Until he discovered EVO implantable lenses, a cutting-edge vision correction procedure that was “a good fit for my eyes and the perfect solution for me.”

The EVO ICL Difference

Jimmy's decision to choose EVO ICL was driven by several remarkable benefits that “made me feel safe with this option”:

  1. Minimally Invasive Procedure: EVO ICL offers a minimally invasive approach and a safe way to correct nearsightedness, with or without astigmatism.
  2. Quick Recovery: The procedure's quick recovery time impressed Jimmy, and he was back to his normal activities the next day.
  3. Effective Vision Correction: EVO ICL provided Jimmy with an excellent quality of vision1,2 without inducing dry eye syndrome3,4.
  4. Removability and Flexibility: The possibility that a doctor can remove the lenses and/or replace them in the future gave Jimmy peace of mind, knowing he has options.

Since undergoing the EVO ICL procedure, Jimmy's life has been transformed.

“It's made my life much easier. I don't have to worry about the hassle of constantly putting on and taking off my glasses, I can play basketball without worrying about contacts, I can swim and actually see the end of the swimming pool. And now I can finally wear cool sunglasses over my amazing eyeballs.”

In Jimmy's own words, his message to anyone on the fence about getting EVO ICL is simple:

"We're so used to wearing glasses and contacts that we sometimes forget how much of a hassle they are. EVO ICL has made my life much simpler, and if I ever want to throw on an old pair of glasses for looks, I still can, without having to pay for the expensive prescription."

If you're tired of the daily hassles of glasses and contacts, consider following in his footsteps and embrace a future with clear, sharp EVO-vision1,5, just like Jimmy.

References:

1. Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125.

2. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215.

3. Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017;11:1253-1263.

4. Naves J.S, Carracedo G, Cacho-Babillo I, Diadenosine nucleotid measurements as dry-eye score in patients after LASIK and ICL surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.

5. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration clinical trial. Clinical Ophthalmology. 2022;16:1541-53.

Web jimmy testimonial page image section break

Prêt à découvrir la liberté visuelle grâce à EVO ICL? Trouver un médecin aujourd’hui

Informations importantes sur la sécurité

La lentille EVO ICL est conçue pour la correction de la myopie modérée à élevée (-0,5 à -20,0 dioptries) et pour la réduction de la myopie chez les patients ayant jusqu’à -20 dioptries de myopie avec 6,0 dioptries ou moins d’astigmatisme. Elle est indiquée pour les patients âgés de 21 à 60 ans. Pour vous assurer que le chirurgien utilisera une lentille EVO ICL dont la puissance convient le mieux à votre œil, votre myopie doit être stable depuis au moins un an avant que vous subissiez une chirurgie oculaire. Il a été documenté que la chirurgie EVO ICL permet de corriger de manière sûre et efficace la myopie entre -0,5 dioptrie et -20,0 dioptries et de corriger partiellement la myopie jusqu’à -20 dioptries dans les yeux ayant jusqu’à 6,0 dioptries d’astigmatisme. Si votre myopie est comprise dans ces plages, la chirurgie EVO ICL peut améliorer votre acuité visuelle de loin sans lunettes ou lentilles de contact. La chirurgie EVO ICL n’élimine pas le besoin de lunettes de lecture, même si vous n’en avez jamais porté auparavant. La lentille EVO ICL représente une solution de rechange à d’autres chirurgies réfractives dont la kératomileusie in situ au laser (LASIK), la kératectomie photoréfractive (PRK), les interventions chirurgicales incisionnelles ou d’autres moyens de corriger la myopie, comme les lentilles de contact et les lunettes. La lentille EVO ICL n’est pas destinée à corriger un astigmatisme que vous pourriez avoir. L’implantation de la lentille EVO ICL est une intervention chirurgicale et comporte par conséquent des risques qui pourraient être graves. Veuillez lire le livret d’information pour le patient et parler des risques avec votre spécialiste de la vision. Les facteurs suivants représentent des complications ou des événements indésirables potentiels signalés en conjonction avec la chirurgie réfractive en général : irritation conjonctivale, enflure cornéenne aiguë, enflure cornéenne persistante, endophtalmie (infection oculaire totale), éblouissement et/ou halos importants autour des lumières, hyphéma (sang dans l’œil), hypopyon (pus dans l’œil), infection de l’œil, déplacement de la lentille EVO ICL, œdème maculaire, pupille non réactive, glaucome par bloc pupillaire, inflammation grave de l’œil, iritis, uvéite, perte vitréenne et greffe de la cornée. Avant d’envisager une chirurgie EVO ICL, vous devez subir un examen complet des yeux et parler de la chirurgie EVO ICL avec votre professionnel de la vision, en particulier de ses avantages, de ses risques et des complications potentielles. Vous devez parler du temps nécessaire pour la cicatrisation après l’intervention chirurgicale.

Références

Références

1. Patient Survey, STAAR Surgical ICL Data Registry, 2018

2. Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46. Patient Survey, STAAR Surgical ICL Data Registry, 2018

3. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.

4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.

5a. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.

5b. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.

*American Refractive Surgery Council